| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.65▼ | 1.68▼ | 1.68▼ | 1.64▼ | 1.89▼ |
| MA10 | 1.70▼ | 1.70▼ | 1.70▼ | 1.66▼ | 2.10▼ |
| MA20 | 1.73▼ | 1.76▼ | 1.78▼ | 1.88▼ | 2.64▼ |
| MA50 | 1.90▼ | 1.94▼ | 1.96▼ | 2.21▼ | 2.61▼ |
| MA100 | 2.14▼ | 2.32▼ | 2.36▼ | 2.73▼ | N/A |
| MA200 | 2.58▼ | 2.83▼ | 2.93▼ | 3.08▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.003▼ | -0.003▼ | -0.010▼ | -0.143▼ |
| RSI | 33.135▼ | 33.963▼ | 34.554▼ | 35.426▼ | 38.078▼ |
| STOCH | 23.077 | 28.571 | 28.571 | 25.656 | 20.768 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -87.302▼ | -95.370▼ |
| CCI | -125.069▼ | -121.635▼ | -121.839▼ | -102.221▼ | -129.531▼ |
|
Monday, December 15, 2025 12:08 AM
Silexion Therapeutics is developing RNA interference (RNAi) therapies aimed at KRAS-driven cancers - among the most prevalent and historically difficult-to-treat oncogenic drivers in solid tumors such ...
|
|
Monday, December 15, 2025 12:08 AM
Silexion Therapeutics is developing RNA interference (RNAi) therapies aimed at KRAS-driven cancers - among the most prevalent and historically difficult-to-treat oncogenic drivers in solid tumors such ...
|
|
Friday, March 28, 2025 06:30 AM
Grand Cayman, Cayman Islands, March 28, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/02/26 | 1.60 | 1.62 | 1.5408 | 1.59 | 47,352 |
| 12/02/26 | 1.68 | 1.69 | 1.55 | 1.58 | 26,600 |
| 11/02/26 | 1.67 | 1.79 | 1.625 | 1.65 | 28,972 |
| 10/02/26 | 1.69 | 1.81 | 1.65 | 1.65 | 44,111 |
| 09/02/26 | 1.73 | 1.80 | 1.71 | 1.75 | 64,600 |
| 06/02/26 | 1.61 | 1.7193 | 1.58 | 1.61 | 22,893 |
| 05/02/26 | 1.70 | 1.7991 | 1.51 | 1.51 | 23,771 |
| 04/02/26 | 1.81 | 1.84 | 1.70 | 1.73 | 12,117 |
| 03/02/26 | 1.83 | 1.875 | 1.755 | 1.77 | 14,561 |
| 02/02/26 | 1.84 | 1.85 | 1.76 | 1.80 | 15,324 |
|
|
||||
|
|
||||
|
|